PapersFlow Research Brief
Metabolism and Genetic Disorders
Research Guide
What is Metabolism and Genetic Disorders?
Metabolism and genetic disorders is the study and clinical practice of diagnosing, explaining, and managing inherited diseases in which gene variants disrupt biochemical pathways, leading to characteristic metabolite abnormalities and organ dysfunction.
The Metabolism and Genetic Disorders literature cluster comprises 194,892 works spanning biochemical genetics, inborn errors of metabolism, and clinical biochemistry, with strong emphasis on laboratory measurement of metabolites and pathway interpretation.
Topic Hierarchy
Research Sub-Topics
Newborn Screening for Inborn Errors of Metabolism
This sub-topic advances tandem mass spectrometry (MS/MS) protocols for early detection of metabolic disorders in neonates. Researchers optimize panels, false positives, and follow-up diagnostics for conditions like MSUD and GA1.
Phenylketonuria Pathophysiology and Treatment
Studies detail PAH gene mutations, phenylalanine hydroxylase dysfunction, and hyperphenylalaninemia management via low-phe diets and sapropterin. Long-term outcomes and maternal PKU syndrome are key foci.
Mitochondrial Disorders in Metabolism
Researchers investigate oxidative phosphorylation defects, mtDNA mutations, and bioenergetic failures in metabolic diseases. Diagnostic tools include muscle biopsies and next-gen sequencing.
Carnitine Metabolism Defects
This area covers primary/secondary carnitine deficiencies, CPT deficiencies, and VLCAD mutations impairing fatty acid beta-oxidation. Treatment trials evaluate L-carnitine supplementation efficacy.
Tetrahydrobiopterin Biosynthesis and BH4 Disorders
Studies elucidate GCH1, PTS, QDPR pathway defects causing BH4 deficiency, neurotransmitter imbalances, and hyperphenylalaninemia. BH4 responsiveness testing and gene therapy prospects are explored.
Why It Matters
Metabolic genetic disorders are clinically actionable because biochemical measurements can enable diagnosis, risk stratification, and treatment monitoring, including in time-sensitive settings such as newborn screening and acute metabolic decompensation. Foundational clinical chemistry methods remain central to metabolic diagnostics: “A PHOTOMETRIC ADAPTATION OF THE SOMOGYI METHOD FOR THE DETERMINATION OF GLUCOSE” (1944) established a practical approach to glucose quantification, and Sedlák and Lindsay’s “Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent” (1968) provided a widely used strategy for assessing thiol redox status relevant to oxidative stress phenotypes. Lipid and membrane-associated pathology is also common in inherited metabolic disease and mitochondrial disorders; Folch et al.’s “A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES” (1957) underpins lipid extraction workflows that support biochemical characterization of lipid storage and mitochondrial membrane changes. Mechanistically, Lin and Beal’s “Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases” (2006) synthesized evidence linking mitochondrial impairment and oxidative stress to neurologic degeneration, a theme that overlaps with many mitochondrial inborn errors presenting with seizures and encephalopathy. In clinical practice, standardized laboratory processes and definitions matter for patient safety and trial eligibility; “National Committee for Clinical Laboratory Standards” (1980) reflects the role of laboratory standardization in pediatrics, and Fisher et al.’s “ILAE Official Report: A practical clinical definition of epilepsy” (2014) provides a practical seizure-disorder definition relevant to metabolic epilepsies and mitochondrial encephalopathies.
Reading Guide
Where to Start
Start with “The Metabolic Basis of Inherited Disease.” (1988) because it is explicitly organized around inherited metabolic conditions and provides a clinically oriented scaffold for connecting pathways, biomarkers, and phenotypes.
Key Papers Explained
A practical reading sequence begins with broad disease organization and then moves to core laboratory methods. “The Metabolic Basis of Inherited Disease.” (1988) and Chen’s “The metabolic and molecular bases of inherited disease” (2001) provide the conceptual map of inborn errors and their molecular/biochemical logic. That framework is operationalized by assay papers used to generate diagnostic evidence: Nelson’s “A PHOTOMETRIC ADAPTATION OF THE SOMOGYI METHOD FOR THE DETERMINATION OF GLUCOSE” (1944) for carbohydrate-related phenotypes, Warren’s “The Thiobarbituric Acid Assay of Sialic Acids” (1959) for sialic-acid–related glyco-phenotypes, Sedlák and Lindsay’s “Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent” (1968) for redox/thiol status, and Folch et al.’s “A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES” (1957) for lipid extraction. Lin and Beal’s “Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases” (2006) connects biochemical dysfunction to neurologic outcomes, while Fisher et al.’s “ILAE Official Report: A practical clinical definition of epilepsy” (2014) provides a standardized clinical endpoint frequently relevant to metabolic encephalopathies.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Within the constraints of this provided paper list, the most immediate frontier is tighter integration of standardized laboratory practice with mechanism-based interpretation: applying assay-derived biochemical signals (glucose, lipids, thiols, sialic acids) to mechanistic hypotheses about mitochondrial dysfunction and oxidative stress as synthesized in “Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases” (2006), and then mapping those hypotheses to clinically operational neurologic phenotypes using “ILAE Official Report: A practical clinical definition of epilepsy” (2014). A second frontier is reproducibility and comparability of biochemical genetics results across sites, which aligns with the laboratory standardization emphasis reflected in “National Committee for Clinical Laboratory Standards” (1980).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LI... | 1957 | Journal of Biological ... | 64.3K | ✓ |
| 2 | National Committee for Clinical Laboratory Standards | 1980 | PEDIATRICS | 14.8K | ✕ |
| 3 | Estimation of the number of nucleotide substitutions in the co... | 1993 | Molecular Biology and ... | 11.3K | ✓ |
| 4 | A PHOTOMETRIC ADAPTATION OF THE SOMOGYI METHOD FOR THE DETERMI... | 1944 | Journal of Biological ... | 10.3K | ✓ |
| 5 | Estimation of total, protein-bound, and nonprotein sulfhydryl ... | 1968 | Analytical Biochemistry | 7.9K | ✕ |
| 6 | The Metabolic Basis of Inherited Disease. | 1988 | Annals of Internal Med... | 7.8K | ✕ |
| 7 | The metabolic and molecular bases of inherited disease | 2001 | Medical Entomology and... | 6.9K | ✕ |
| 8 | The Thiobarbituric Acid Assay of Sialic Acids | 1959 | Journal of Biological ... | 6.4K | ✓ |
| 9 | Mitochondrial dysfunction and oxidative stress in neurodegener... | 2006 | Nature | 6.3K | ✕ |
| 10 | ILAE Official Report: A practical clinical definition of epilepsy | 2014 | Epilepsia | 5.6K | ✕ |
In the News
Infant with rare, incurable disease is first to successfully ...
Funding for this project was provided by the NIH Common Fund Somatic Cell Genome Editing program grants, U01TR005355, U19NS132301, U19NS132303, DP2CA281401, and National Heart, Lung, and Blood Inst...
Groundbreaking Metabolism Research Receives $6.8 ...
the liver communicates with the heart and how metabolic dysfunction contributes to cardiovascular disease. His lab has recently secured more than**$6.8 million in research funding**across three maj...
NIH awards more than $15 million to fund two rare ...
The ROAR Consortium will conduct clinical and translational research on organic acidemias, a group of genetic metabolic disorders in which there is a defect in protein and energy metabolism. Baylor...
World's First Patient Treated with Personalized CRISPR Gene Editing Therapy at Children’s Hospital of Philadelphia
### $14M NIH grant funds gene-editing research for rare metabolic diseases at Penn and CHOP Researchers aim to develop personalized therapies for urea cycle disorders and other genetic conditions u...
CRISPR Combo Offers Hope for Early Treatment of Rare ...
A study fromDukeresearchersin pediatrics and molecular genetics and microbiologyshows that genome editing could be a promising and safe long-term treatment for infants with glycogen storage disease...
Code & Tools
## About For untargeted metabolomics, this tool calculates probability scores for metabolic disorders. In addition, it provides visual support wit...
This is a python implementation of DEXOM (Diversity-based enumeration of optimal context-specific metabolic networks)
**GPRuler** (metabolic **G** ene- **P** rotein- **R** eaction **rule** s automatic reconstruction) is an open-source tool to automate the reconstru...
Genobolitics is a bioinformatics tool that extends Metabolitics to include gene expression data for pathway-level analysis of diseases. This projec...
The MDK is a modular Java open source library for simplifying procedures when handling metabolic models
Recent Preprints
A genetic map of human metabolism across the allele frequency spectrum
Genetic studies of human metabolism have been limited in scale and allelic breadth. Here we provide a data-driven map of the genetic regulation of circulating small molecules and lipoprotein charac...
Genetic architecture of plasma metabolome in 254,825 individuals
Circulating metabolites are crucial to biological processes underlying health and diseases, yet their genetic determinants remain incompletely understood. Here, we investigate the genetic architect...
Circulating metabolites, genetics and lifestyle factors in relation to future risk of type 2 diabetes
The human metabolome reflects complex metabolic states affected by genetic and environmental factors. However, metabolites associated with type 2 diabetes (T2D) risk and their determinants remain i...
Optimizing gene prioritization for clinical diagnosis of metabolic genetic disorders
Inherited metabolic disorders (IMDs) comprise a heterogeneous group of rare genetic diseases that, although individually uncommon, have a significant cumulative incidence [ 1 – 2 ]. Approximately 1...
Inherited metabolic disorders: presentation, clinical types, laboratory diagnosis and genetic markers
Inherited metabolic disorders (IMDs) are classified under rare genetic diseases almost always presenting in newborn and infants. IMDs are classified according to the clinical presentation, diagnosi...
Latest Developments
Recent research in metabolism and genetic disorders includes expanding the genetic landscape of inherited metabolic diseases using long-read sequencing and transcriptomic profiling (Nature, as of January 2026), the development of a genetic map of human metabolism across the allele frequency spectrum (Nature Genetics, October 2025), and studies on the genetic associations of human metabolic traits (Nature Genetics, April 2024). Additionally, research continues on the pathophysiology, diagnosis, and treatment of rare genetic metabolic diseases supported by institutions like the NIDDK (NIDDK, as of 2026).
Sources
Frequently Asked Questions
What are metabolism and genetic disorders in clinical biochemistry terms?
Metabolism and genetic disorders are inherited conditions in which gene defects alter enzymes, transporters, or organelle functions, producing measurable changes in metabolites and biochemical markers. The field integrates biochemical assays, pathway reasoning, and clinical phenotyping to diagnose and manage inborn errors of metabolism, including mitochondrial and amino-acid–related disorders described across this literature cluster (194,892 works).
How are core metabolites and biochemical phenotypes measured in this literature?
Core biochemical phenotypes are often measured with standardized quantitative assays that translate chemistry into clinically interpretable concentrations. For example, “A PHOTOMETRIC ADAPTATION OF THE SOMOGYI METHOD FOR THE DETERMINATION OF GLUCOSE” (1944) describes a practical glucose determination approach, and “The Thiobarbituric Acid Assay of Sialic Acids” (1959) describes an assay framework for sialic acids relevant to glycosylation-related phenotypes.
Which laboratory methods are most foundational for lipid-related metabolic phenotyping?
A key foundational method is Folch et al.’s “A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES” (1957), which established a broadly applicable approach to extracting total lipids from tissues. Lipid extraction is a prerequisite for many downstream measurements used to characterize lipid storage, membrane composition, and metabolic remodeling in inherited disorders.
How does mitochondrial biology connect to metabolic genetic disorders with neurologic presentations?
Many inherited metabolic disorders affect energy production and redox balance, which can manifest as neurodegeneration, encephalopathy, or seizures. Lin and Beal’s “Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases” (2006) consolidates the mechanistic link between mitochondrial dysfunction and oxidative stress, providing a framework often applied when interpreting mitochondrial inborn errors with neurologic phenotypes.
Which reference works organize the clinical and molecular knowledge base for inherited metabolic disease?
Two highly cited reference syntheses in this list are “The Metabolic Basis of Inherited Disease.” (1988) and Chen’s “The metabolic and molecular bases of inherited disease” (2001). These works are commonly used to structure disorder classification, connect biochemical pathways to clinical phenotypes, and guide diagnostic reasoning.
Which standards and clinical definitions affect how metabolic disorder complications are classified in practice?
Laboratory standardization influences comparability and reliability of biochemical results, as reflected by “National Committee for Clinical Laboratory Standards” (1980). Neurologic complications are often framed using clinical definitions such as Fisher et al.’s “ILAE Official Report: A practical clinical definition of epilepsy” (2014), which is relevant when metabolic disorders present with recurrent seizures.
Open Research Questions
- ? Which biochemical assay choices (e.g., glucose, sulfhydryl/redox, sialic acid, lipid extraction) most strongly affect diagnostic sensitivity and specificity for specific inborn errors when applied across laboratories, and how should they be standardized in practice as implied by “National Committee for Clinical Laboratory Standards” (1980)?
- ? How can mechanistic models linking mitochondrial dysfunction to oxidative stress, as synthesized in “Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases” (2006), be translated into clinically validated biomarker panels for mitochondrial inborn errors with neurologic phenotypes?
- ? Which lipid classes and extraction/handling variables (building on “A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES” (1957)) best discriminate primary lipid metabolic defects from secondary lipid remodeling in mitochondrial disease?
- ? How should seizure phenotypes in suspected metabolic disease be operationalized for diagnosis, prognosis, and trial endpoints using Fisher et al.’s “ILAE Official Report: A practical clinical definition of epilepsy” (2014) alongside biochemical evidence?
- ? Which measurement frameworks for glyco-metabolic phenotypes (as in “The Thiobarbituric Acid Assay of Sialic Acids” (1959)) best support differential diagnosis among disorders with overlapping neurologic and systemic features?
Recent Trends
This topic cluster is large (194,892 works) and is anchored by enduring laboratory methods and reference syntheses that remain heavily cited, including “A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES” , “A PHOTOMETRIC ADAPTATION OF THE SOMOGYI METHOD FOR THE DETERMINATION OF GLUCOSE” (1944), and “The Metabolic Basis of Inherited Disease.” (1988).
1957The most visible thematic consolidation in the top-cited set is the emphasis on mitochondria and oxidative stress as a unifying explanation for neurologic morbidity, captured by Lin and Beal’s “Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases” , alongside increased reliance on standardized clinical definitions for neurologic outcomes such as Fisher et al.’s “ILAE Official Report: A practical clinical definition of epilepsy” (2014).
2006Research Metabolism and Genetic Disorders with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Metabolism and Genetic Disorders with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers